FR21C1002I1 - Vaccin pour la protection contre lawsonia intracellularis - Google Patents

Vaccin pour la protection contre lawsonia intracellularis

Info

Publication number
FR21C1002I1
FR21C1002I1 FR21C1002C FR21C1002C FR21C1002I1 FR 21C1002 I1 FR21C1002 I1 FR 21C1002I1 FR 21C1002 C FR21C1002 C FR 21C1002C FR 21C1002 C FR21C1002 C FR 21C1002C FR 21C1002 I1 FR21C1002 I1 FR 21C1002I1
Authority
FR
France
Prior art keywords
vaccine
protection against
lawsonia intracellularis
against lawsonia
intracellularis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR21C1002C
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Intervet International BV
Original Assignee
Intervet International BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41212183&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FR21C1002(I1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Intervet International BV filed Critical Intervet International BV
Publication of FR21C1002I1 publication Critical patent/FR21C1002I1/fr
Active legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/105—Delta proteobacteriales, e.g. Lawsonia; Epsilon proteobacteriales, e.g. campylobacter, helicobacter
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
FR21C1002C 2008-04-18 2021-01-18 Vaccin pour la protection contre lawsonia intracellularis Active FR21C1002I1 (fr)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US4616108P 2008-04-18 2008-04-18
EP08154764 2008-04-18
US11175608P 2008-11-06 2008-11-06
EP08105738 2008-11-06
PCT/EP2009/054516 WO2009144088A2 (fr) 2008-04-18 2009-04-16 Vaccin pour une protection contre lawsonia intracellularis
EP09753743.5A EP2268308B1 (fr) 2008-04-18 2009-04-16 Vaccin pour la protection contre lawsonia intracellularis

Publications (1)

Publication Number Publication Date
FR21C1002I1 true FR21C1002I1 (fr) 2021-03-05

Family

ID=41212183

Family Applications (1)

Application Number Title Priority Date Filing Date
FR21C1002C Active FR21C1002I1 (fr) 2008-04-18 2021-01-18 Vaccin pour la protection contre lawsonia intracellularis

Country Status (13)

Country Link
US (3) US20110033496A1 (fr)
EP (3) EP3708186A1 (fr)
JP (2) JP6026106B2 (fr)
CN (1) CN102006883A (fr)
BR (2) BRPI0909769A2 (fr)
CA (1) CA2717969C (fr)
DK (2) DK2268308T3 (fr)
ES (1) ES2666671T3 (fr)
FR (1) FR21C1002I1 (fr)
HU (2) HUE038294T2 (fr)
PL (2) PL2268308T3 (fr)
TW (1) TWI551295B (fr)
WO (1) WO2009144088A2 (fr)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI551295B (zh) * 2008-04-18 2016-10-01 英特威特國際股份有限公司 防備胞內勞森菌（Ｌａｗｓｏｎｉａ ｉｎｔｒａｃｅｌｌｕｌａｒｉｓ）用疫苗
ES2606131T3 (es) 2009-11-09 2017-03-22 Intervet International B.V. Método para cultivar bacterias Lawsonia intracellularis en células McCoy infectadas de forma persistente
KR101837768B1 (ko) 2011-05-25 2018-03-12 건국대학교 산학협력단 돼지 증식성 회장염을 진단하기 위한 단백질 및 그 응용
US10130699B2 (en) 2013-12-03 2018-11-20 Intervet Inc. Vaccine against Lawsonia intracellularis and porcine circovirus 2
CN110354258A (zh) 2013-12-03 2019-10-22 英特维特国际股份有限公司 抗猪圆环病毒2型的疫苗
WO2015082465A1 (fr) * 2013-12-03 2015-06-11 Intervet International B.V. Vaccin porcin contre le pprs et lawsonia intracellularis
JP2018504424A (ja) * 2015-02-04 2018-02-15 インターベット インターナショナル ベー． フェー． 豚における無症候性ローソニア感染症に対する使用のためのワクチン
JP2018504423A (ja) * 2015-02-04 2018-02-15 インターベット インターナショナル ベー． フェー． 豚における無症候性ローソニア感染症に対する使用のためのワクチン
JP6906511B2 (ja) * 2015-10-22 2021-07-21 インターベット インターナショナル ベー． フェー． ローソニア・イントラセルラリス感染から生じる障害に対してｍｄａ陽性動物を防御するためのワクチン
JP6655414B2 (ja) 2016-02-15 2020-02-26 株式会社デンソー 排気浄化システム
US20200323975A1 (en) 2017-12-04 2020-10-15 Intervet Inc. Vaccination with replicon particles and oil adjuvant
EP3727444A1 (fr) 2017-12-18 2020-10-28 Intervet International B.V. Vaccin contre le virus de la grippe porcine de type a
US10792352B2 (en) 2018-02-28 2020-10-06 Boehringer Ingelheim Vetmedica Gmbh Method for reducing skatole and/or indole in animals
US20230277649A1 (en) 2020-06-19 2023-09-07 Intervet Inc. Swine influenza a virus vaccine comprising two distinct rna replicon particles
CN115768785A (zh) 2020-06-19 2023-03-07 英特维特国际股份有限公司 包含含有编码病毒的不同神经氨酸酶抗原的第一、第二和第三核酸序列的核酸构建体的甲型猪流感病毒疫苗
EP4168041A1 (fr) 2020-06-19 2023-04-26 Intervet International B.V. Vaccin contre le virus de la grippe a porcine, comprenant une construction d'acide nucléique comportant un ordre spécifique de gènes
WO2021255221A1 (fr) 2020-06-19 2021-12-23 Intervet International B.V. Vaccin contre le virus de la grippe porcine comprenant une construction d'acide nucléique codant pour des antigènes de lignées de virus spécifiques
WO2023072805A1 (fr) 2021-10-25 2023-05-04 Intervet International B.V. Vaccin pour la protection de porcelets contre une infection par le virus de la grippe porcine a
AU2022375120A1 (en) 2021-11-01 2024-04-11 Boehringer Ingelheim Vetmedica Gmbh Immunogenic gel compositions
WO2024068637A1 (fr) 2022-09-27 2024-04-04 Intervet International B.V. Procédé de culture de bactéries lawsonia intracellularis

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0382271B1 (fr) 1989-02-04 1994-12-21 Akzo Nobel N.V. Tocols comme adjuvants de vaccins
FR2649012B1 (fr) 1989-07-03 1991-10-25 Seppic Sa Emulsions multiphasiques injectables
US5885823A (en) 1995-06-05 1999-03-23 Nobl Laboratories, Inc. Lawsonia intracellularis cultivation, anti-Lawsonia intracellularis vaccines and diagnostic agents
NZ322398A (en) * 1995-11-30 2000-02-28 Pig Res & Dev Corp Vaccine compositions comprising non-pathogenic form of Lawsonia intracellularis, nucleic acid sequences thereof and treatment of intestinal disease
NZ515363A (en) * 1999-05-13 2003-07-25 Pfizer Prod Inc Lawsonia derived gene and related hemolysin polypeptides, peptides and proteins and their uses
EP1094070A3 (fr) 1999-10-22 2002-01-09 Pfizer Products Inc. Protéines de Lawsonia intracellularis et procédés et matériaux relatifs à ces protéines
JP2004529854A (ja) 2000-09-29 2004-09-30 アリゾナ・ボード・オブ・リージエンツ・オン・ビハーフ・オブ・ザ・ユニバーシテイー・オブ・アリゾナ 増殖性回腸炎のための改善されたワクチン及びその作製と使用の方法
EP1586646B1 (fr) 2000-12-20 2011-03-09 Intervet International BV Lawsonia intracellularis vaccin
SG144909A1 (en) 2003-07-25 2008-08-28 Boehringer Ingelheim Vetmed Lawsonia intracellularis of european origin and vaccines, diagnostic agents and methods of use thereof
EP1709067B1 (fr) 2004-01-22 2010-06-09 Intervet International BV Vaccin a sous-unité de lawsonia intracellularis
KR20070008625A (ko) * 2004-04-05 2007-01-17 화이자 프로덕츠 인코포레이티드 미세유체화된 수중유 유화액 및 백신 조성물
EP2305294B1 (fr) * 2004-09-22 2015-04-01 GlaxoSmithKline Biologicals SA Composition immunogène pour la vaccination contre des staphylocoques
US20070212373A1 (en) 2004-12-08 2007-09-13 Akzo Nobel N.V. Lawsonia Intracellularis 26 Kd Subunit Vaccine
US8834891B2 (en) * 2005-03-14 2014-09-16 Boehringer Ingelheim Vetmedica, Inc. Immunogenic compositions comprising Lawsonia intracellularis
US8398994B2 (en) * 2005-07-15 2013-03-19 Boehringer Ingelheim Vetmedica, Inc. Lawsonia vaccine and methods of use thereof
US20080248061A1 (en) 2005-09-09 2008-10-09 Intervet International B.V. Pcv-2 Vaccine
BRPI0708522A2 (pt) 2006-03-03 2011-05-31 Merial Ltd vacina de mycoplasma hyopneumoniae
EP2476434A1 (fr) * 2006-03-30 2012-07-18 GlaxoSmithKline Biologicals S.A. Composition immunogène
WO2007116032A1 (fr) 2006-04-10 2007-10-18 Intervet International B.V. Vaccin contre un mycoplasme prrsv
US8470336B2 (en) * 2006-05-25 2013-06-25 Boehringer Ingelheim Vetmedica, Inc. Vaccination of young animals against Lawsonia intracellularis infections
MX2008015164A (es) 2006-05-30 2008-12-12 Intervet Int Bv Vacuna contra organismos de tipo rickettsia.
TWI449533B (zh) 2008-04-18 2014-08-21 Intervet Int Bv 防備胞內勞森菌（Ｌａｗｓｏｎｉａ ｉｎｔｒａｃｅｌｌｕｌａｒｉｓ）、豬肺炎黴漿菌（Ｍｙｃｏｐｌａｓｍａ ｈｙｏｐｎｅｕｍｏｎｉａｅ）及豬環狀病毒（Ｐｏｒｃｉｎｅ ｃｉｒｃｏ ｖｉｒｕｓ）用疫苗
TWI551295B (zh) * 2008-04-18 2016-10-01 英特威特國際股份有限公司 防備胞內勞森菌（Ｌａｗｓｏｎｉａ ｉｎｔｒａｃｅｌｌｕｌａｒｉｓ）用疫苗
JP2018504424A (ja) 2015-02-04 2018-02-15 インターベット インターナショナル ベー． フェー． 豚における無症候性ローソニア感染症に対する使用のためのワクチン

Also Published As

Publication number Publication date
EP3351267A1 (fr) 2018-07-25
JP6026106B2 (ja) 2016-11-16
ES2666671T3 (es) 2018-05-07
US20130302372A1 (en) 2013-11-14
PL3351267T3 (pl) 2020-11-30
WO2009144088A2 (fr) 2009-12-03
CN102006883A (zh) 2011-04-06
CA2717969C (fr) 2016-06-07
US9198963B2 (en) 2015-12-01
HUE038294T2 (hu) 2018-10-29
JP2016026154A (ja) 2016-02-12
US20130045228A1 (en) 2013-02-21
WO2009144088A3 (fr) 2010-05-06
BR122019000869B1 (pt) 2023-11-07
EP3708186A1 (fr) 2020-09-16
DK2268308T3 (en) 2018-05-22
US8597662B2 (en) 2013-12-03
EP2268308A2 (fr) 2011-01-05
US20110033496A1 (en) 2011-02-10
EP3351267B1 (fr) 2020-08-05
PL2268308T3 (pl) 2018-07-31
TWI551295B (zh) 2016-10-01
DK3351267T3 (da) 2020-09-21
TW201002342A (en) 2010-01-16
HUS2000047I1 (hu) 2020-12-28
JP6138875B2 (ja) 2017-05-31
CA2717969A1 (fr) 2009-12-03
EP2268308B1 (fr) 2018-03-14
JP2011516600A (ja) 2011-05-26
BRPI0909769A2 (pt) 2015-08-11

Similar Documents

Publication Publication Date Title
FR21C1002I1 (fr) Vaccin pour la protection contre lawsonia intracellularis
BRPI0910283A2 (pt) conjunto de ensacamento
ZA201101481B (en) Vaccine
DK2114993T3 (da) Vaccine
IL211184A0 (en) Polyvalent vaccine
HRP20151124T1 (en) Vaccine
BRPI1005919A2 (pt) composição imunogênica
DK2341834T3 (da) Forbedret røntgenbeskyttelse
GB0700135D0 (en) Vaccine
GB0810869D0 (en) Vaccine adjuvant composition
GB0810710D0 (en) Vaccine
ZA201007402B (en) Vaccine
GB0816284D0 (en) Vaccine
GB0805356D0 (en) Vaccine adjuvant composition
EP2252326A4 (fr) Compositions de vaccin
GB0816447D0 (en) Vaccine
GB0801122D0 (en) Vaccine composition
HUE051465T2 (hu) Vakcina Lawsonia intracellularis elleni védelemre
GB0820404D0 (en) Vaccine compositions
GB0802326D0 (en) Vaccine Composition
UA16875S (uk) Упаковка для шоколаду
GB0702363D0 (en) Vaccine composition
UA16478S (uk) Упаковка для фіточаю
TH101459B (th) สิ่งบรรจุเพื่อการหีบห่อ
UA18024S (uk) Упаковка для фіточаю